Proszowice, Poland Clinical Trials
A listing of Proszowice, Poland clinical trials actively recruiting patients volunteers.
Found 45 clinical trials
Promoting Reengagement in Daily Meaningful Activity Intervention for adults with mild cognitive impairment and their caregivers
The PRIMA project is design to help persons with mild cognitive impairment to help them to improve their engagement in personally meaningful activity and improve their overall quality of life with their family caregivers support. The goal of PRIMA project is to increase persons with mild cognitive impairment’s engagement in …
- 439 views
- 23 Sep, 2022
- 1 location
- Online study
Alzheimer's Disease Center Research Registry
This study is looking for people over the age of 55 who have normal cognition, memory problems, or mild dementia. The study is also looking for people who are care partners of someone who has dementia. The study is intended to match people with studies that may be a good …
- 428 views
- 23 Sep, 2022
- 1 location
- Online study
Genetic Testing for Common Disorders: Learning from the Experiences of Individuals who were Tested to Determine their Genetic Risk for Alzheimer’s Disease
This study is looking for people who have the APOE-e4 gene, which is associated with a higher risk for developing Alzheimer’s disease. The study is interested in learning about participants’ experiences.IMPORTANT: This communication is meant only to make you aware of an opportunity to participate in a research study. The …
- 1616 views
- 23 Sep, 2022
- 1 location
- Online study
Objective, Passive Assessment of LRRK2 Carriers (OPAL)
This study is currently only open to active participants in the University of Rochester’s VALOR-PD study. The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless …
- 64 views
- 12 May, 2022
- 1 location
- Online study
A Phase 1b, Open Label, Global, Multicenter, Dose Determination, Randomized Dose Expansion Study to Determine the Maximum Tolerated Dose, Assess the Safety and Tolerability, Pharmacokinetics and Preliminary Efficacy of Iberdomide (CC-220) in Combination With R-CHOP-21 and CC-99282 in Combination With R-CHOP-21 for Subjects With Previously Untreated, Aggressive B-cell Lymphoma
This is a Phase 1b study consisting of 2 parts: a dose escalation (Part 1) of CC-220 or CC-99282 added to the standard R-CHOP-21 regimen for first-line treatment of a-BCL. The dose escalation (Part 1) will consist of 2 parallel arms in combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone …
- 1 views
- 25 Oct, 2022
- +19 other locations